EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cholesterol Drives IFITM3 + Microglia Activation and Induces STING Mediated Neuroinflammation After Ischemic Stroke

Cholesterin treibt IFITM3+-Mikroglia-Aktivierung an und induziert STING-vermittelte Neuroinflammation nach ischämischem Schlaganfall

Yue Cheng iD, Yuxi Zhou iD, Yonghui Chen, Tianni Shen, Yan Li, Chen Chen, Qiuyue Fan, Jie Qi, Peiying Li iD, Yueman Zhang iD

CNS Neuroscience & Therapeutics · 2026-08 · 32 (8)

DOI: 10.1002/cns.71073 ↗

Auf einen Blick

In Mausmodellen und mit scRNA-seq wurde eine IFITM3+-Mikroglia-Subpopulation beschrieben, die nach Schlaganfall mit Cholesterinbelastung und Entzündung zusammenhing. HβCD oder STING-Hemmung wirkten protektiv.

Fragestellung

Welche cholesterinassoziierten Mikroglia-Subpopulationen und Signalwege tragen nach ischämischem Schlaganfall zur Neuroinflammation bei?

Methode

dMCAO-Modell mit scRNA-seq; Cholesterindynamik, Lipidtröpfchen und Entzündungsmarker per Immunfluoreszenz und Elektronenmikroskopie; Interventionen mit HβCD, C-176 und AAV9-STING-Knockdown.

Ergebnisse

IFITM3+ Mikroglia zeigten ACAT1-Überexpression, Cholesterinesterifizierung, Cholesterinkristalle und Lipidtröpfchen; Peak 7 Tage post-Stroke. HβCD und C-176 senkten Infarktgröße, Demyelinisierung und verbesserten Motorik.

Schlussfolgerung der Autor:innen

IFITM3+ Mikroglia sind eine proinflammatorische, cholesterinbeladene Subpopulation, die ischämische Hirnschädigung verstärkt. HβCD oder STING-Hemmung erscheinen als therapeutische Strategie.

Kernaussagen

  • IFITM3+ Mikroglia korrelierten mit NLRP3-Inflammasom und STING-Signalweg
  • HβCD verringerte Lipidtröpfchen und STING-Aktivierung
  • HβCD und C-176 verbesserten Infarkt, Myelin und Motorik

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 11.08.2026. Verfasst von Yue Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Microglia, Neuroinflammatory Diseases, Cholesterol, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Shanghai Engineering Research Center of Peri-operative Organ Support and Function Preservation.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cerebral ischemic stroke triggers extensive neuronal membrane breakdown, releasing a massive load of cholesterol that overwhelms resident microglia. Dysregulated microglial cholesterol metabolism has been implicated in post‐stroke neuroinflammation, yet the specific pathogenic microglial subpopulations, their molecular signatures, and the downstream inflammatory cascades remain poorly defined.

Methods

We employed a permanent distal middle cerebral artery occlusion (dMCAO) model combined with single‐cell RNA sequencing (scRNA‐seq) to profile immune cell transcriptomes and identify cholesterol‐associated microglial markers. Cholesterol dynamics, lipid droplet accumulation, and inflammatory marker expression were quantified via immunofluorescence and transmission electron microscopy. Therapeutic interventions included pharmacological cholesterol mobilization with 2‐hydroxypropyl‐β‐cyclodextrin (HβCD), pharmacological STING inhibition with C‐176, and microglia‐targeted STING knockdown using AAV9 vectors. Cerebral injury and neurological function were assessed through infarct volume measurement, white matter integrity analysis, and behavioral assays (rotarod and grip strength) in dMCAO, tMCAO, and perioperative stroke (PIS) models.

Results

Using scRNA‐seq, we identified interferon‐induced transmembrane protein 3 (IFITM3) as a specific marker for a microglial subpopulation that was characterized by upregulated ACAT1, enhanced cholesterol esterification, and accumulation of cholesterol crystals and lipid droplets. This IFITM3 + microglia population peaked at 7 days post‐stroke and correlated with NLRP3 inflammasome activation and STING signaling. Pharmacological reduction of cholesterol burden with HβCD attenuated lipid droplet formation, suppressed mitochondrial DNA leakage, and inhibited STING pathway activation. Correspondingly, HβCD and C‐176 administration significantly reduced cerebral infarct size, mitigated white matter demyelination, and improved motor function in dMCAO and tMCAO models. We further found that AAV‐mediated STING knockdown recapitulated the above protective effects in HβCD and C‐176 treated stroke mice. Furthermore, HβCD treatment ameliorated microglial inflammation and improved functional outcomes in a PIS model.

Conclusion

IFITM3 + microglia is a pro‐inflammatory and cholesterol‐laden subpopulation that exacerbates post‐stroke cerebral ischemic brain injury. Targeting the microglial cholesterol axis by HβCD or inhibiting the STING pathway represents a promising therapeutic strategy to mitigate ischemic brain injury and improve neurological function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaNeuroinflammatory DiseasesCholesterolMembrane ProteinsIschemic StrokeRNA-Binding ProteinsAnimalsMiceMaleSTING ProteinMice, Inbred C57BLcGAS-STING Signaling PathwayInfarction, Middle Cerebral Artery

Stichwörter der Autor:innen

STINGcholesterolischemic strokemicroglianeuroinflammation

Substanzen

CholesterolSTING ProteinMembrane ProteinsRNA-Binding ProteinsSting1 protein, mouse

Autor:innen und Institutionen

  • Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Key Laboratory of Anesthesiology, Shanghai Jiao Tong University, Ministry of Education, Shanghai, China.
  • Clinical Research Center, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Yue Cheng, Yuxi Zhou, Peiying Li, Yueman Zhang

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Shanghai Engineering Research Center of Peri-operative Organ Support and Function Preservation
  • China Postdoctoral Science Foundation
  • Postdoctoral Fellowship Program of CPSF

Zitieren

APA

Cheng, Y., Zhou, Y., Chen, Y., Shen, T., Li, Y., Chen, C., Fan, Q., Qi, J., Li, P., & Zhang, Y. (2026). Cholesterol Drives IFITM3 + Microglia Activation and Induces STING Mediated Neuroinflammation After Ischemic Stroke. CNS Neuroscience & Therapeutics, 32(8). https://doi.org/10.1002/cns.71073

Vancouver

Cheng Y, Zhou Y, Chen Y, Shen T, Li Y, Chen C, et al. Cholesterol Drives IFITM3 + Microglia Activation and Induces STING Mediated Neuroinflammation After Ischemic Stroke. CNS Neuroscience & Therapeutics. 2026;32(8). doi:10.1002/cns.71073

BibTeX
@article{Cheng2026,
  author = {Cheng, Yue and Zhou, Yuxi and Chen, Yonghui and Shen, Tianni and Li, Yan and Chen, Chen and Fan, Qiuyue and Qi, Jie and Li, Peiying and Zhang, Yueman},
  title = {Cholesterol Drives IFITM3 + Microglia Activation and Induces STING Mediated Neuroinflammation After Ischemic Stroke},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {8},
  doi = {10.1002/cns.71073}
}
Kostenlos starten →